The Patent Finder
PT

PS Therapies Ltd.

First filing 2011
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 5 US patents in force on its record. from the record

Of the 5 now held by other companies, 5 name PS Therapy Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2015 to 2038.
US 8,999,938 Ophthalmic Lipophilic Drug Delivery Vehicle Formulations Jun 21, 2033
US 8,933,006 Contact Lens Cleaning Compositions Jun 21, 2033
US 11,583,496 Drug Vehicle Compositions and Methods of Use Thereof no later than Oct 12, 2037
US 11,260,035 Topical Compositions and Methods of Use Thereof no later than Oct 20, 2037
US 10,918,586 Topical Compositions and Methods of Use Thereof Dec 4, 2038
20202025203020352038
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 7 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2037. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
now held by PS Therapy, Inc.
Ends no later than Oct 2037 · Medium confidence
Also notable
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2033.
now held by PS Therapy, Inc.
Ends Jun 2033 · High confidence
Also notable
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
now held by PS Therapy, Inc.
Ends Jun 2033 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 5 patents in force now held by others · 3 patents ended · 13 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
3 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed
2 computed term dates come from a chain with an unresolved parent. A continuity parent has not yet been fetched from USPTO's records. The term is dated from this application's own claim; no earlier date is assumed until the parent is resolved.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited